Concepedia

Florian Rosar

FR

Statistics

Publications

35

Citations

1.4K

H-Index

24

Active since

2019

Affiliations

Saarland University(Current)

Johannes Gutenberg University Mainz

Universitätsklinikum des Saarlandes

Federal Ministry of Defence

Radboud University Nijmegen

Florian Rosar is an author at Saarland University specializing in medicine, nuclear medicine, and prostate cancer.

ORCID

Publications per year

2019–2024

35

Publications

35

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

Fadi Khreish, Niklas Ebert, Martin Ries et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 213 citations

, , +16

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)

Fadi Khreish, Zaidoon Ghazal, Robert J. Marlowe et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 89 citations · Full text

, , +17

Molecular imaging and biochemical response assessment after a single cycle of [<sup>225</sup>Ac]Ac-PSMA-617/[<sup>177</sup>Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [<sup>177</sup>Lu]Lu-PSMA-617 monotherapy

Florian Rosar, Fabian Hau, Mark Bartholomä et al. · Theranostics · 2021 · 82 citations · Full text

, , +17

Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis

Florian Rosar, Jonas Krause, Mark Bartholomä et al. · Pharmaceutics · 2021 · 59 citations · Full text

, , +17

Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease

Fadi Khreish, Florian Rosar, Clemens Kratochwil et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 56 citations

, , +16

1–5 of 35